Annual CFI
-$16.18 M
+$150.36 M+90.28%
31 December 2023
Summary:
Castle Biosciences annual cash flow from investing activities is currently -$16.18 million, with the most recent change of +$150.36 million (+90.28%) on 31 December 2023. During the last 3 years, it has fallen by -$11.44 million (-240.84%). CSTL annual CFI is now -5742.24% below its all-time high of -$277.00 thousand, reached on 31 December 2018.CSTL Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$14.79 M
+$6.63 M+30.95%
30 September 2024
Summary:
Castle Biosciences quarterly cash flow from investing activities is currently -$14.79 million, with the most recent change of +$6.63 million (+30.95%) on 30 September 2024. Over the past year, it has dropped by -$5.08 million (-52.34%). CSTL quarterly CFI is now -189.18% below its all-time high of $16.58 million, reached on 31 March 2023.CSTL Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$63.58 M
-$5.08 M-8.69%
30 September 2024
Summary:
Castle Biosciences TTM cash flow from investing activities is currently -$63.58 million, with the most recent change of -$5.08 million (-8.69%) on 30 September 2024. Over the past year, it has dropped by -$50.59 million (-389.33%). CSTL TTM CFI is now -222204.20% below its all-time high of -$28.60 thousand, reached on 31 March 2018.CSTL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +90.3% | -52.3% | -389.3% |
| 3 y3 years | -240.8% | -1502.3% | -74.9% |
| 5 y5 years | -5742.2% | -8809.0% | -10000.0% |
CSTL Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -240.8% | +90.3% | -189.2% | +89.0% | -389.3% | +67.0% |
| 5 y | 5 years | -5742.2% | +90.3% | -189.2% | +89.0% | <-9999.0% | +67.0% |
| alltime | all time | -5742.2% | +90.3% | -189.2% | +89.0% | <-9999.0% | +67.0% |
Castle Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$14.79 M(-30.9%) | -$63.58 M(+8.7%) |
| June 2024 | - | -$21.42 M(+8.7%) | -$58.50 M(+11.5%) |
| Mar 2024 | - | -$19.70 M(+156.8%) | -$52.47 M(+224.2%) |
| Dec 2023 | -$16.18 M(-90.3%) | -$7.67 M(-21.0%) | -$16.18 M(+24.6%) |
| Sept 2023 | - | -$9.71 M(-36.9%) | -$12.99 M(-90.5%) |
| June 2023 | - | -$15.39 M(-192.8%) | -$137.44 M(-8.1%) |
| Mar 2023 | - | $16.58 M(-470.0%) | -$149.56 M(-10.2%) |
| Dec 2022 | -$166.54 M(+149.9%) | -$4.48 M(-96.7%) | -$166.54 M(-13.7%) |
| Sept 2022 | - | -$134.15 M(+387.6%) | -$192.95 M(+223.1%) |
| June 2022 | - | -$27.51 M(+6743.5%) | -$59.73 M(-9.9%) |
| Mar 2022 | - | -$402.00 K(-98.7%) | -$66.31 M(-0.5%) |
| Dec 2021 | -$66.66 M | -$30.89 M(+3246.6%) | -$66.66 M(+83.3%) |
| Sept 2021 | - | -$923.00 K(-97.3%) | -$36.36 M(-2.6%) |
| June 2021 | - | -$34.09 M(+4446.0%) | -$37.34 M(+647.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$750.00 K(+27.6%) | -$5.00 M(+5.3%) |
| Dec 2020 | -$4.75 M(+406.7%) | -$588.00 K(-69.1%) | -$4.75 M(+5.3%) |
| Sept 2020 | - | -$1.90 M(+8.4%) | -$4.51 M(+62.8%) |
| June 2020 | - | -$1.76 M(+251.2%) | -$2.77 M(+132.1%) |
| Mar 2020 | - | -$500.00 K(+44.1%) | -$1.19 M(+27.3%) |
| Dec 2019 | -$937.00 K(+238.3%) | -$347.00 K(+109.0%) | -$937.00 K(+57.4%) |
| Sept 2019 | - | -$166.00 K(-7.8%) | -$595.40 K(+15.3%) |
| June 2019 | - | -$180.00 K(-26.2%) | -$516.40 K(+4.9%) |
| Mar 2019 | - | -$244.00 K(+4418.5%) | -$492.40 K(+77.8%) |
| Dec 2018 | -$277.00 K(-44.0%) | -$5400.00(-93.8%) | -$277.00 K(+2.0%) |
| Sept 2018 | - | -$87.00 K(-44.2%) | -$271.60 K(+47.1%) |
| June 2018 | - | -$156.00 K(+445.5%) | -$184.60 K(+545.5%) |
| Mar 2018 | - | -$28.60 K | -$28.60 K |
| Dec 2017 | -$494.90 K | - | - |
FAQ
- What is Castle Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Castle Biosciences?
- What is Castle Biosciences annual CFI year-on-year change?
- What is Castle Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Castle Biosciences?
- What is Castle Biosciences quarterly CFI year-on-year change?
- What is Castle Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Castle Biosciences?
- What is Castle Biosciences TTM CFI year-on-year change?
What is Castle Biosciences annual cash flow from investing activities?
The current annual CFI of CSTL is -$16.18 M
What is the all time high annual CFI for Castle Biosciences?
Castle Biosciences all-time high annual cash flow from investing activities is -$277.00 K
What is Castle Biosciences annual CFI year-on-year change?
Over the past year, CSTL annual cash flow from investing activities has changed by +$150.36 M (+90.28%)
What is Castle Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of CSTL is -$14.79 M
What is the all time high quarterly CFI for Castle Biosciences?
Castle Biosciences all-time high quarterly cash flow from investing activities is $16.58 M
What is Castle Biosciences quarterly CFI year-on-year change?
Over the past year, CSTL quarterly cash flow from investing activities has changed by -$5.08 M (-52.34%)
What is Castle Biosciences TTM cash flow from investing activities?
The current TTM CFI of CSTL is -$63.58 M
What is the all time high TTM CFI for Castle Biosciences?
Castle Biosciences all-time high TTM cash flow from investing activities is -$28.60 K
What is Castle Biosciences TTM CFI year-on-year change?
Over the past year, CSTL TTM cash flow from investing activities has changed by -$50.59 M (-389.33%)